Jacks Lee
Vermogen: 398 539 $ op 30-06-2026
Vermogen: 398 539 $ op 30-06-2026
Jacks Lee worked as Senior Vice President-Manufacturing & Supply at Merck & Co., Inc. from 2007 to 2023.
Served as Independent Director at G1 Therapeutics, Inc. from 2022 to 2024.
Served as Independent Director at Vaxcyte, Inc. from 2023 to 2026.
Education includes graduate degree from the University of Central Missouri and undergraduate degree from the University of Wisconsin.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 6.856 ( 0% ) | 398 539 $ | 30-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| VAXCYTE, INC. | Directeur/Bestuurslid | 17-06-2026 |
| G1 THERAPEUTICS, INC. | Directeur/Bestuurslid | 18-09-2024 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-06-2023 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
University of Central Missouri
University of Central Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau